Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion

Clinical Cancer Research

Volumn 9, Issue 11, 2003, Pages 4145-4150

  Im, Samuel S ^a   Wilczynski, Sharon P ^b   Burger, Robert A ^a   Monk, Bradley J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; HYSTERECTOMY; INCIDENCE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; PELVIS LYMPH NODE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STROMA CELL; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; DNA, VIRAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MARITAL STATUS; MIDDLE AGED; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 0141455140     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Parkin, D. M., Pisani, P., and Ferlay, J. Estimates of worldwide incidence from 25 major cancers in 1990. Int. J. Cancer, 80: 827-841, 1999.
2. Pisani, P., Parkin, D. M., Bray, F., and Ferlay, J. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83: 18-29, 1999.
3. Walboomers, J. M., Jacobs, M. V., and Manos, M. M. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189: 12-19, 1999.
4. Stoler, M. H. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int. J. Gynecol. Pathol., 19: 16-28, 2000.
5. Dupuy, C., Buzoni-Gatel, D., Touze, A., Bout, D., and Coursaget, P. Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes. J. Virol., 73: 9063-9071, 1999.
6. Burger, R. A., Monk, B. J., Kurosaki, T., Anton-Culver, H., Vasilev, S. A., Berman, M. L., and Wilczynski, S. P. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J. Natl. Cancer Inst. (Bethesda), 88: 1361-1368, 1996.
7. Nakagawa, S., Yoshikawa, H., Onda, T., Kawana, T., Iwamoto, A., and Taketani, Y. Type of human papillomavirus is related to clinical features of cervical carcinoma. Cancer (Phila.), 78: 1935-1941, 1996.
8. Lombard, I., Vincent-Salomon, A., Validire, P., Zafrani, B., de la Rochefordiere, A., Clough, K., Favre, M., Pouillart, P., and Sastre-Garau, X. Human papillomavirus genotype as a major determinant of the course of cervical cancer. J. Clin. Oncol., 16: 2613-2619, 1998.
9. Schwartz, S. M., Daling, J. R., Shera, K. A., Madeleine, M. M., McKnight, B., Galloway, D. A., Porter, P. L., and McDougall, J. K. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J. Clin. Oncol., 19: 1906-1915, 2001.
10. Resnick, R. M., Cornelissen, M. T., Wright, D. K., Eichinger, G. H., Fox, H. S., ter Schegget, J., and Manos, M. M. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J. Natl. Cancer Inst. (Bethesda), 82: 1477-1484, 1990.
11. Monk, B. J., Cook, N., Ahn, C., Vasilev, S. A., Berman, M. L., and Wilczynski, S. P. Comparison of the polymerase chain reaction and southern blot analysis in detecting and typing human papilloma virus deoxyribonucleic acid in tumors of the lower female genital tract. Diagn. Mol. Pathol., 3: 283-291, 1994.
12. Monk, B. J., Cha, D. S., Walker, J. L., Burger, R. A., Ramsinghani, N. S., Manetta, A., DiSaia, P. J., and Berman, M. L. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Gynecol. Oncol., 54: 4-9, 1994.
13. Barnes, W., Delgado, G., Kurman, R. J., Petrilli, E. S., Smith, D. M., Ahmed, S., Lorincz, A. T., Temple, G. F., Jenson, A. B., and Lancaster, W. D. Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol. Oncol., 29: 267-273, 1988.
14. Walker, J., Bloss, J. D., Liao, S. Y., Berman, M., Bergen, S., and Wilczynski, S. P. Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet. Gynecol., 74: 781-785, 1989.
15. Riou, G., Favre, M., Jeannel, D., Bourhis, J., Le Doussal, V., and Orth, G. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet, 335: 1171-1174, 1990.
16. Higgins, G. D., Davy, M., Roder, D., Uzelin, D. M., Phillips, G. E., and Burrell, C. J. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet, 338: 910-913, 1991.
17. van Bommel, P. F., van den Brule, A. J., Helmerhorst, T. J., Gallee, M. P., Gaarenstroom, K. N., Walboomers, J. M., Meijer, C. J., and Kenemans, P. HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancer. Gynecol. Oncol., 48: 333-337, 1993.
18. Rose, B. R., Thompson, C. H., Simpson, J. M., Jarrett, C. S., Elliott, P. M., Tattersall, M. H., Dalrymple, C., and Cossart, Y. E. Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: a possible role for type 18. Am. J. Obstet. Gynecol., 173: 1461-1468, 1995.
19. Zhang, J., Rose, B. R., Thompson, C. H., Jarrett, C., Russell, P., Houghton, R. S., and Cossart, Y. E. Associations between oncogenic human papillomaviruses and local invasive patterns in cervical cancer. Gynecol. Oncol., 57: 170-177, 1995.
20. Lo, K. W., Cheung, T. H., Chung, T. K., Wang, V. W., Poon, J. S., Li, J. C., Lam, P., and Wong, Y. F. Clinical and prognostic significance of human papillomavirus in a Chinese population of cervical cancers. Gynecol. Obstet. Invest., 51: 202-207, 2001.
21. Pilch, H., Gunzel, S., Schaffer, U., Tanner, B., Brockerhoff, P., Maeurer, M., Hockel, M., Hommel, G., and Knapstein, P. G. The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int. J. Gynecol. Cancer, 11: 39-48, 2001.
22. Cullen, A. P., Reid, R., Campion, M., and Lorincz, A. T. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol., 65: 606-612, 1991.
23. Stoler, M. H., Rhodes, C. R., Whitbeck, A., Wolinsky, S. M., Chow, L. T., and Broker, T. R. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol., 23: 117-128, 1992.
24. Park, J. S., Hwang, E. S., Park, S. N., Ahn, H. K., Um, S. J., Kim, C. J., Kim, S. J., and Namkoong, S. E. Physical status and expression of HPV genes in cervical cancers. Gynecol. Oncol., 65: 121-129, 1997.
25. Werness, B. A., Levine, A. J., and Howley, P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (Wash. DC), 248: 76-79, 1990.
26. Kurman, R. J., Schiffman, M. H., Lancaster, W. D., Reid, R., Jenson, A. B., Temple, G. F., and Lorincz, A. T. Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am. J. Obstet. Gynecol., 159: 293-296, 1988.
27. Woodman, C. B., Collins, S., Rollason, T. P., Winter, H., Bailey, A., Yates, M., and Young, L. S. Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia. Lancet, 361: 40-43, 2003.
28. Benedet, J. L., Odicino, F., Masionneuve, P., Beller, U., Creasman, W. T., Heintz, A. P. M., Ngan, H. Y. S., Sideri, M., and Pecorelli, S. Carcinoma of the cervix uteri. J. Epidemiol. Biostat., 6: 5-44, 2001.
29. Sedlis, A., Bundy, B. N., Rotman, M. Z., Lentz, S. S., Muderspach, L. I., and Zaino, R. J. A. randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol. Oncol., 73: 177-183, 1999.
30. Peters, W. A., III, Liu, P. Y., Barrett, R. J., II, Stock, R. J., Monk, B. J., Berek, J. S., Souhami, L., Grigsby, P., Gordon, W., Jr., and Alberts, D. S. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol., 18: 1606-1613, 2000.